| 000 | 01549 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515062458.0 | ||
| 264 | 0 | _c20070626 | |
| 008 | 200706s 0 0 eng d | ||
| 022 | _a0001-2815 | ||
| 024 | 7 |
_a10.1111/j.1399-0039.2007.00816.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMartínez, A | |
| 245 | 0 | 0 |
_aEpistatic interaction between FCRL3 and MHC in Spanish patients with IBD. _h[electronic resource] |
| 260 |
_bTissue antigens _cApr 2007 |
||
| 300 |
_a313-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aEpistasis, Genetic |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 |
_aHLA Antigens _xbiosynthesis |
| 650 | 0 | 4 |
_aHLA-DR Antigens _xgenetics |
| 650 | 0 | 4 | _aHLA-DRB1 Chains |
| 650 | 0 | 4 | _aHeterozygote |
| 650 | 0 | 4 |
_aHistocompatibility Antigens _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammatory Bowel Diseases _xethnology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 650 | 0 | 4 |
_aReceptors, Immunologic _xgenetics |
| 650 | 0 | 4 | _aSpain |
| 700 | 1 | _aNúñez, C | |
| 700 | 1 | _aMartín, M C | |
| 700 | 1 | _aMendoza, J L | |
| 700 | 1 | _aTaxonera, C | |
| 700 | 1 | _aDíaz-Rubio, M | |
| 700 | 1 | _ade la Concha, E G | |
| 700 | 1 | _aUrcelay, E | |
| 773 | 0 |
_tTissue antigens _gvol. 69 _gno. 4 _gp. 313-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1399-0039.2007.00816.x _zAvailable from publisher's website |
| 999 |
_c16943163 _d16943163 |
||